Richman, Douglas D.
Douglas Richman American virologist
Richman, Douglas D., 1943-...., professeur de pathologie et de médecine
Richman, Douglas D., 1943-
VIAF ID: 65748137 (Personal)
Permalink: http://viaf.org/viaf/65748137
Preferred Forms
- 100 0 _ ‡a Douglas Richman ‡c American virologist
-
-
- 100 1 _ ‡a Richman, Douglas D.
-
-
- 100 1 _ ‡a Richman, Douglas D.
-
-
- 100 1 _ ‡a Richman, Douglas D.
-
- 100 1 _ ‡a Richman, Douglas D.
- 100 1 _ ‡a Richman, Douglas D.
-
-
- 100 1 _ ‡a Richman, Douglas D., ‡d 1943-...., ‡c professeur de pathologie et de médecine
4xx's: Alternate Name Forms (7)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Absence of detectable HIV-1 viremia after treatment cessation in an infant | |
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement | |
Antiviral Drug Discovery To Address the COVID-19 Pandemic | |
Antiviral drug resistance | |
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size | |
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs | |
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals | |
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient | |
Clinical virology | |
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies | |
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. | |
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals | |
Encyclopedia of AIDS | |
Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types | |
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study. | |
The Future of HIV-1 Therapeutics : Resistance Is Futile? | |
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. | |
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment | |
HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat | |
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. | |
HIV-associated neurocognitive disorder is associated with HIV-1 dual infection | |
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor | |
HIV type 1 | |
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment | |
Human immunodeficiency virus | |
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection | |
Improved assays to measure and characterize the inducible HIV reservoir | |
International AIDS Society global scientific strategy: towards an HIV cure 2016. | |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation | |
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections | |
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128. | |
A new perspective on V3 phenotype prediction. | |
A Plea for Justice for Jailed Medical Workers | |
Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations | |
Public health. A sound rationale needed for phase III HIV-1 vaccine trials | |
Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs | |
Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR | |
Recommendations for measuring HIV reservoir size in cure-directed clinical trials | |
Replicate Aptima assay for quantifying residual plasma viremia in individuals on ART | |
Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV | |
Select host restriction factors are associated with HIV persistence during antiretroviral therapy | |
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance | |
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection | |
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study |